Ask most patients considering abdominoplasty or body contouring what weight they need to be for surgery, and they will usually answer with a number — a BMI, a dress size, a figure on the scale. It is a natural question to ask, but it is the wrong one. The question that actually predicts whether an operation will produce a good, lasting result is not "what do you weigh today?" but "what will you weigh in five years?"

I wrote previously about the concept of "happy weight" in the context of NHS breast reduction criteria — the idea that a thoughtful surgeon should ask not what a patient weighs on the day of assessment, but what weight they are realistically likely to maintain over the long term. That concept has become considerably more relevant in the last two years, for a reason that did not exist when most of the established thinking on weight and surgical candidacy was written: the widespread availability of GLP-1 weight-loss medications, and a steady rise in bariatric surgery referrals from patients who are now, for the first time, close to a body they are happy with.

Why Stability Matters More Than the Number

Operations such as abdominoplasty, body contouring and, to a lesser extent, breast surgery, work by removing or repositioning tissue to match the body you have at the time of the operation. The result is only as durable as your weight is stable afterwards. Significant weight gain after abdominoplasty can stretch the repaired muscle wall and re-accumulate fat in ways that visibly compromise the result. Significant further weight loss after body contouring can leave new areas of skin laxity that were not present, or not addressed, at the time of surgery.

This is why "happy weight" is a more useful clinical concept than BMI on the day of consultation. A patient who has been steady at a given weight for two or three years, eats consistently, and has no major weight change planned is often a better candidate for a durable surgical result than a patient who happens to be lighter on paper but is still actively losing weight, mid-diet, or newly started on a weight-loss medication with months of change still ahead of them.

The GLP-1 Effect: A New Route to Happy Weight

GLP-1 receptor agonists — semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro) among them — have changed the population of patients arriving at a plastic surgery consultation. Many patients who spent years unable to lose weight through diet and exercise alone have, over months on these medications, reached a genuinely stable, healthy weight for the first time in their adult lives. For this group, the medication has not been a short-term crash diet; it has been the mechanism by which they finally reached their happy weight.

The practical question this raises for surgical timing is straightforward in principle, even if the specifics need to be individualised: has the weight loss actually stopped, or slowed to a genuine maintenance phase, and is that phase likely to hold? A patient still losing weight rapidly month to month is not yet at their happy weight, however encouraging their progress. A patient who has been on a stable maintenance dose, at a stable weight, for a meaningful period is in a very different position. This is a conversation to have openly with both your surgeon and your prescriber — including whether you plan to continue, reduce or stop the medication after surgery, since that decision affects how stable your result is likely to remain.

Skin Quality: Rapid Weight Loss Behaves Differently

One pattern that plastic surgeons are increasingly discussing, based on clinical observation, is that rapid pharmacological weight loss can leave skin looking and behaving differently from the same amount of weight lost gradually over years. Skin has some capacity to retract as the tissue beneath it shrinks, but that capacity depends partly on how quickly the change happens, as well as on age, skin quality and genetics. Patients who lose a large amount of weight quickly sometimes describe a deflated quality to the skin — of the face as well as the body — that is a distinct pattern from the excess skin seen after traditional weight loss over a longer period. This does not make surgery any less appropriate; if anything, it is one of the reasons body contouring referrals from this patient group have increased. But it is worth understanding as a distinct pattern, not simply "the same as after bariatric surgery, only faster."

Bariatric Surgery and the Case for Staged Treatment

For patients who reach their happy weight through bariatric surgery rather than medication, the established principle remains: body contouring is planned as a separate, later stage, not combined with the weight-loss procedure itself. Waiting until weight has been stable for at least 6 months allows nutritional status to recover — which matters directly for wound healing — and gives both patient and surgeon a true picture of the excess skin and tissue that actually needs to be addressed, rather than operating on a moving target.

The same logic increasingly applies to GLP-1 patients considering major body contouring. It is not that medication-assisted weight loss is treated with more suspicion than surgical weight loss; it is that the underlying surgical principle — operate on a stable body, not a body still in transition — applies regardless of how the weight was lost.

What This Means in Practice

If you are considering abdominoplasty, body contouring, breast surgery or any procedure where a durable result depends on your weight remaining stable afterwards, it is worth being candid at consultation about:

A good surgeon will use this information to advise honestly on timing — sometimes that means proceeding now, and sometimes it means waiting a further few months until your weight has genuinely settled. Either way, the goal is the same one that "happy weight" was always meant to capture: a result that still looks right in five years, not just five weeks.